NANOG and ovarian cancer: In addition, c-MYC expression has been most often proposed as a general feature of the CSCs of various cancers including breast [50], prostate [51], esophagus [52] and tongue [53], and the expression of c-MYC together with NANOG has been previously noted as a feature in a population of ovarian cancer cells [27].